Sharps Technology, Inc. (STSS)
STSS Chart as of 2025-03-10
Stock Information
| CEO: | – |
| CFO: | – |
| Employees: | 57 |
| Address: | 105 Maxess Road, Melville, NY, United States |
| Country: | United States |
| Website: | https://sharpstechnology.com |
| Listing Date: | – |
| Founded: | – |
| Founder: | – |
| Current Price: | 0.4936 USD |
| Today Change: | 66.20% |
| Outstanding Shares: | 11,078,000 |
| Volume: | 19,948,953 |
| Avg Volume: | 3,929,774 |
| Expert Target Price: | – (Institutions: 0) |
| EPS: | – |
| PER: | – |
| Dividend Date: | – |
| Last Split Date: | 2024-10-16 |
| Last Split Factor: | 1:22 |
Key Executives
| Name | Title | Pay | Year |
|---|---|---|---|
| Mr. Robert M. Hayes | CEO & Director | 600.89k | — |
| Mr. Andrew R. Crescenzo CPA | Chief Financial Officer | 236.04k | — |
| Mr. Ben Scheu | Senior Director of Sales | — | — |
| Mr. Frank Parrado | Corporate Controller | — | — |
Financials
Income Statement
| Metric | Amount |
|---|---|
| Total Revenue | 0 |
| Cost Of Revenue | – |
| Gross Profit | – |
| Operating Income | -10,126,650 |
| Net Income | -9,841,638 |
Balance Sheet
| Metric | Amount |
|---|---|
| Total Assets | 11,789,268 |
| Total Liabilities | – |
| Total Stockholder Equity | – |
Cash Flow
| Metric | Amount |
|---|---|
| Total Cash From Operating Activities | – |
| Capital Expenditures | – |
SEC Filings (Gemini Summaries)
| AccNo | Date | Summary |
|---|---|---|
| 0001493152-25-005899 | 2025-02-11 | Sharps Technology, Inc. will hold a special stockholder meeting on March 28, 2025, to vote on: a reverse stock split (ratio 1-for-3 to 1-for-11), authorization of warrant issuance, and adjournment options. |
| 9999999995-25-000353 | 2025-02-07 | Sharps Technology Inc.’s filing (333-284237) was declared effective by the SEC on Feb 7, 2025. |
| 0001999371-25-001230 | 2025-02-05 | This SEC filing text defines CSS styles for formatting text boxes and tables. Key elements include borders, font sizes/colors, and word wrapping. Table styles specify border widths, layouts, and alignment. |
| 0000921895-25-000215 | 2025-01-31 | CSS styling for tables and textboxes. Defines borders, fonts, colors, and alignment for various table elements (th, td). Also defines formatting for a fake textbox. |
| 0001493152-25-004438 | 2025-01-31 | Sharps Tech requests SEC consent to withdraw Amendment No. 3 to its S-1 registration statement (File No. 333-284237), filed after the registration statement was declared effective. |
News Summary
– Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan
2025-02-24 05:00:00 | Cdc.gov
Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan
Link
– ThermoMaze behavioral paradigm for assessing immobility-related brain events in rodents
2025-03-07 00:00:00 | Elifesciences.org
Brain states fluctuate between exploratory and consummatory phases of behavior. These state changes affect both internal computation and the organism’s responses to sensory inputs. Understanding neuronal mechanisms supporting exploratory and consummatory stat…
Link
– Association between prenatal exposure to maternal metal and trace elements and Streptococcus infection: A prospective birth cohort in the Japan Environment and Children’s Study
2025-02-27 14:00:00 | Plos.org
Background Streptococcus infection is a common and potentially severe bacterial infection which remains a global public health challenge, underscoring the necessity of investigating potential risk factors. Aims The present study aims to assess the associati…
Link
Analysis of Today’s Rally
Sharps Technology (STSS) experienced a significant stock rally today. The rally appears unrelated to typical market drivers or company performance news. Rather, the catalyst seems to be a confluence of unrelated, yet subtly connected, news items and SEC filings. This connection, though tenuous, may have sparked speculative interest.
The first piece of the puzzle is the CDC report on rising Streptococcal Toxic Shock Syndrome (STSS) cases in Japan. This highlights a potential global health concern relating to streptococcus infections. Secondly, a study links prenatal exposure to metals and trace elements with increased streptococcus infection risk. This strengthens the narrative around the seriousness of streptococcal infections.
Sharps Technology has existing SEC filings, including one declaring a previous filing effective. This makes the company identifiable for investors actively monitoring SEC activity. The upcoming stockholder meeting to vote on a reverse stock split may also play a role. Reverse stock splits can often lead to short-term price increases, albeit unsustainably.
The speculative interest may stem from a perceived, though likely unfounded, connection. Sharps Technology might be misconstrued as having solutions addressing rising STSS rates. This speculation could arise from those who scanned medical journals and SEC filings. It is important to highlight that the firm is not mentioned in any of the articles.
Consequently, investors should exercise extreme caution before investing based on this perceived relationship. The rally appears to be driven by speculation and is not substantiated by company news. Fundamental analysis and due diligence are essential when making investment decisions. A correction is likely as reality sets in.
This stock has shown a change of 66.20% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.
The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.
Leave a Reply